AstraZeneca Vaxzevria COVID-19 Vaccine
Vaxzevria uses chimpanzee adenovirus vector expressing SARS-CoV-2 spike for immunity. Retail multi-dose vials qualify under HTS 3002.15.00 immunological products.
Import Duty Rates by Country of Origin
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If replicating viral vectors
Replication-competent vectors as micro-organism cultures.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Shake well before dose; silicone-free syringes required
• TTS (thrombosis) risk labeling mandatory
• Live vector elements may trigger 3002.30 review
Related Products under HTS 3002.15.00
Pfizer Prevnar 13 Pneumococcal Vaccine
Prevnar 13 is a 13-valent pneumococcal conjugate vaccine used to prevent invasive disease caused by Streptococcus pneumoniae in infants and adults. It contains purified capsular polysaccharides conjugated to a carrier protein, qualifying as an immunological product under HTS 3002.15.00 due to its measured doses packaged for retail sale in pre-filled syringes.
Moderna Spikevax COVID-19 Vaccine
Spikevax is an mRNA-based COVID-19 vaccine encoding the SARS-CoV-2 spike protein to elicit immune response. As a biotechnologically produced immunological product in pre-filled syringes for retail sale, it fits HTS 3002.15.00.
Merck Gardasil 9 HPV Vaccine
Gardasil 9 vaccine targets nine HPV types with virus-like particles (VLPs) for cervical cancer prevention. As a measured-dose retail product, it falls under immunological products of HTS 3002.15.00.
Bavarian Nordic Imvamune Smallpox Vaccine
Imvamune is a non-replicating modified vaccinia Ankara vaccine for smallpox/mpox protection. Its immunological nature and retail dosing qualify for HTS 3002.15.00.
Seqirus Flucelvax Influenza Vaccine
Flucelvax is cell culture-derived inactivated influenza vaccine with four strains. Packaged in measured doses for retail sale, it's an immunological product under HTS 3002.15.00.
Regeneron Casimvy Gene Therapy
Casimvy uses CRISPR/Cas9 ex vivo to edit CD34+ cells for sickle cell disease, administered as immunological cell therapy. As a measured-dose biotech product for retail, it fits HTS 3002.15.00.